A double-blind, controlled trial of nabilone vs. prochlorperazine for refractory emesis induced by cancer chemotherapy

Cancer Treat Rev. 1982 Dec;9 Suppl B:25-33. doi: 10.1016/s0305-7372(82)80032-7.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • Randomized Controlled Trial

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Antiemetics / therapeutic use*
  • Antineoplastic Agents / adverse effects*
  • Clinical Trials as Topic
  • Double-Blind Method
  • Dronabinol / adverse effects
  • Dronabinol / analogs & derivatives*
  • Dronabinol / therapeutic use
  • Female
  • Humans
  • Male
  • Middle Aged
  • Prochlorperazine / adverse effects
  • Prochlorperazine / therapeutic use*
  • Vomiting / chemically induced
  • Vomiting / drug therapy*

Substances

  • Antiemetics
  • Antineoplastic Agents
  • nabilone
  • Dronabinol
  • Prochlorperazine